Mogrify appoints Dr. Jonathan Appleby as Chief Scientific Officer

FHS
July 15, 2024
3:34 pm

Strategic hire bolsters executive leadership team as Company progresses multiple therapeutic programs toward and into clinical development.

Applying antifragility theory to cancer could revolutionize treatment methods

Researchers constantly seek innovative approaches to tackle cancer. One concept gaining traction is antifragility, a property where systems not only withstand stress but improve because

August 1, 2024

UT Health San Antonio and UTSA launch first U.S. MD/MS program in medicine and artificial intelligence

The Joe R. and Teresa Lozano Long School of Medicine at The University of Texas Health Science Center at San Antonio (UT Health San Antonio)

September 14, 2023

‘Sweet spot’ of CNS cell therapy: Kenai emerges with $82M for Parkinson’s study

One of the first drugs that Jeff Jonas filed for approval was a Parkinson’s disease treatment. Now, a little over a quarter-century later, after executive

March 1, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.